SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (6684)5/20/1999 11:38:00 PM
From: Bob L   of 9719
 
I looked at a bunch of NeoRx stuff and couldn't find any explanation of what they mean by "commercially available". It doesn't necessarily mean the same as "approved by FDA". However, I did sort of make a jump in assuming because they worked with NSC on the earlier Avicidan that they also are building their lymphoma one. All their stuff sort of implies that, except for the "commercially available" line. If they mean FDA approved, why the secrecy? (NeoRx frequently refers to it as the "humanized" antibody, without naming it.) We can all list the number of FDA approved lymphoma antibodies pretty easily .... a list of one. Could they mean commercially available in the sense it can be bought for and used for trials, if they get the trial approved?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News